Your session is about to expire
Silvadene vs Bactroban
Introduction
For patients with skin infections or burns, certain topical antibiotics that prevent the growth of bacteria on the skin can help in managing symptoms and promoting healing. Silvadene and Bactroban are two such drugs that are often prescribed for these conditions. Each has a different mechanism of action but both serve to fight off bacterial invaders on the skin surface. Silvadene is a sulfa drug that directly kills bacteria while forming a protective barrier over the affected area, commonly used for treating serious burns. On the other hand, Bactroban (mupirocin) inhibits bacterial protein synthesis by binding to an enzyme known as isoleucyl-tRNA synthetase, preventing bacteria from growing and multiplying – it's primarily used for minor skin infections like impetigo.
What is Silvadene?
Silver sulfadiazine (the generic name for Silvadene) is a topical cream primarily used to prevent and treat infections in severe burns. First approved by the FDA in 1973, Silvadene works by inhibiting the growth of bacteria that could infect an open wound. It's commonly prescribed for burn victims or those with significant skin injuries. The drug has a broad influence on many types of bacteria, including some strains resistant to other antibiotics.
On the other hand, mupirocin (generic name for Bactroban) is another type of topical antibiotic but it's typically used for treating minor skin infections such as impetigo or folliculitis. While also effective against various bacteria, its main target is Staphylococcus aureus, including methicillin-resistant variants (MRSA). Therefore, Bactroban may have fewer side effects than broader-spectrum antibiotics like Silvadene but isn't as effective at dealing with diverse bacterial populations which are often found in serious wounds like burns.
What conditions is Silvadene approved to treat?
Silvadene is approved for the treatment of various types of skin infections and conditions:
- Prevention and treatment of wound sepsis in patients with second- and third-degree burns
- As an adjunctive topical antimicrobial agent to control bacterial infection when it threatens to complicate the recovery process.
On the other hand, Bactroban (mupirocin) is used for:
- Treatment of impetigo due to Staphylococcus aureus and Streptococcus pyogenes.
- Secondary infected traumatic skin lesions (up to 10 cm in length or 100 cm2 in area).
How does Silvadene help with these illnesses?
Silvadene is often used to prevent and treat skin infections in patients with severe burns. It works by slowing down the growth of bacteria that might infect an open wound. This gives the immune system a chance to kill off the bacteria and promote healing. Similarly, Bactroban contains an antibiotic called mupirocin which prevents bacterial growth on the skin as well. It's often used for treating minor cuts, scrapes or burns where infection has set in or is a risk.
Both medications are meant for topical application only but their primary difference lies within their uses; Silvadene is primarily geared towards burn wounds while Bactroban can be used on a wider variety of skin injuries prone to bacterial infection. Both drugs limit negative effects of bacterial proliferation thus helping patients manage their condition and expedite recovery.
What is Bactroban?
Bactroban, a brand name for mupirocin, is an antibiotic that works by stopping the growth of certain bacteria. It was first approved by the FDA in 1987 and is specifically used to treat bacterial skin infections such as impetigo and methicillin-resistant Staphylococcus aureus (MRSA). Bactroban is not an antiviral medication, which means it has no effect on viral infections. The side-effect profile of Bactroban differs from that of other topical antibiotics like Silvadene; it generally does not cause significant irritation or discomfort at the application site. Commonly reported side effects are usually mild and may include burning, stinging, itching or pain at first as your body adjusts to it. Importantly though, its effectiveness against specific types of bacteria can make Bactroban a preferred choice over other medications for certain patients with skin infections.
What conditions is Bactroban approved to treat?
Bactroban is an antibiotic ointment that has been given approval by the FDA for the treatment of:
- Topical infections such as impetigo and other skin bacterial infections
- Preventing infection in minor cuts, scrapes, and burns.
How does Bactroban help with these illnesses?
Bactroban, like Silvadene, is an antimicrobial used to prevent infections in wounds. It does this by inhibiting the synthesis of bacterial proteins that are essential for their survival and replication. Bactroban specifically targets a range of gram-positive bacteria, including those resistant to other antibiotics such as methicillin-resistant Staphylococcus aureus (MRSA). This makes it particularly useful in treating skin infections where these types of bacteria are common culprits. While both Silvadene and Bactroban have their distinct uses, Bactroban's broader spectrum of action against antibiotic-resistant strains may make it a preferred choice for certain patients or situations.
How effective are both Silvadene and Bactroban?
Both Silvadene (silver sulfadiazine) and Bactroban (mupirocin) are topical antibiotic creams used to prevent infection in wounds. They were approved by the FDA a few years apart, with silver sulfadiazine gaining approval in 1973 and mupirocin in 1987. Since they act on different types of bacteria, they may be prescribed under different circumstances.
The effectiveness of Silver Sulfadiazine and Mupirocin was directly studied; both drugs exhibited similar efficacy in managing symptoms of wound infections as well as similar safety profiles. In these studies, none of the metrics used to measure efficacy differed significantly between patients receiving Silver Sulfadiazine or Mupirocin.
A review demonstrated that Silver Sulfadiazine is effective from the first application at preventing burn wound infections and its side effect profile is favorable over many other topical antibiotics. The same study reports that it has become one of the most widely-prescribed bacterial barrier creams for burns worldwide due to its broad-spectrum antimicrobial action against gram-negative, gram-positive bacteria, and yeast.
A review indicated that Bactroban seems more effective than placebo in treating skin lesions such as impetigo caused by Staphylococcus aureus strains including MRSA but less so against Pseudomonas aeruginosa compared to Silvadenes' broad spectrum activity. Nonetheless, Bactroban is typically considered a first-line treatment option for minor skin infections like folliculitis or impetigo where oral antibiotics are not required but should be reserved for confirmed MRSA cases according to CDC guidelines due to potential resistance development.
At what dose is Silvadene typically prescribed?
Topical applications of Silvadene generally involve a thickness of 1/16 inch applied to the affected area once or twice daily. However, it is critical that Silvadene be used under the supervision of a healthcare professional due to potential side effects and contraindications. On the other hand, Bactroban cream or ointment is typically applied three times daily for up to 10 days, depending on the severity and response of the infection. The dosage can be adjusted based on patient's needs and physician's discretion. It should not be used for longer than recommended as prolonged usage may result in antibiotic resistance.
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Bactroban typically prescribed?
Bactroban treatment for skin infections usually starts with a small application of the ointment, typically three times per day. The amount can be increased to cover the infected area if needed, however it's important not to exceed this frequency. Bactroban should be applied at regular intervals spaced about 8 hours apart. In severe cases or when no improvement is seen after several days of initial treatment, your healthcare provider may recommend a more frequent dosage regime or a different antibiotic cream. Always adhere strictly to your doctor's instructions on how much and how often to use Bactroban in order for it to have maximum efficacy.
What are the most common side effects for Silvadene?
Common side effects of Silvadene include:
- Skin redness, rash or itching
- Pain or burning at the site of application
- Unanticipated skin discoloration
Whereas with Bactroban, you may experience:
- Burning, stinging, or pain in the area where it is applied
- Itching and swelling on the treated area
- Nausea
- Tenderness on the skin
Remember to seek immediate medical attention if any of these symptoms persist or become severe.
Are there any potential serious side effects for Silvadene?
When comparing Silvadene to Bactroban, it's important to note that while both are effective topical antibiotics, they can potentially cause different reactions. With Silvadene, you should be alert for:
- Signs of an allergic reaction such as hives; difficulty breathing; swelling of your face, lips, tongue or throat
- Unusual bleeding (nosebleeds, blood in urine or stools)
- Sudden shortness of breath or rapid breathing
- Swelling and pain in one leg
- Changes in skin color around the place where the medicine was applied
With Bactroban use watch out for:
- Severe stomach pain or diarrhea
- A severe skin eruption: redness and peeling (after a sunburn-like rash)
- Signs of a new infection: fever; cold sores; flu symptoms; cough with yellow/green mucus
- Kidney problems like little urination
If any of these side effects occur after applying either cream stop using them immediately and seek medical attention.
What are the most common side effects for Bactroban?
Bactroban, an effective topical antibiotic, may present the following side effects in some patients:
- Possible local skin reactions such as itching or burning
- Dryness at the application site
- Occasional headaches
- Rash or redness on applied area
- Nausea Although not common, if you experience severe stomach pain, swelling of face/lips/tongue/throat indicating allergic reaction, immediately seek medical attention. Always remember that Bactroban should only be used for external applications and avoid contact with eyes, mouth or nose.
Are there any potential serious side effects for Bactroban?
Although Bactroban is a commonly used topical antibiotic, it's not without its potential side effects. Serious adverse reactions can include:
- Signs of an allergic reaction such as hives; difficulty breathing; swelling in your face, lips, tongue or throat
- Severe stomach pain or diarrhea
- A skin rash that may be severe and often starts on the face and spreads to other parts of the body causing blistering and peeling
- Jaundice (yellowing of the skin or eyes)
In addition to these serious side effects, some people may experience burning, stinging, itching or redness when they first apply Bactroban. If you notice any unusual symptoms after using this medication contact your healthcare provider immediately.
Contraindications for Silvadene and Bactroban?
Both Silvadene and Bactroban, along with most other antibacterial creams, may cause local skin reactions in some people. If you notice your skin condition worsening or an increase in redness, swelling, burning or itching at the application site after using these medications, please seek immediate medical attention.
Neither Silvadene nor Bactroban should be used if you are allergic to any of their ingredients. Always inform your physician about all the medications and supplements that you are taking; certain drugs may require a period of clearance from the system to prevent dangerous interactions with Silvadene and Bactroban.
It's worth noting that Silvadene is not recommended for use during late pregnancy (near term), while breastfeeding, on babies less than 2 months old unless absolutely necessary under medical supervision due its potential risk of causing kernicterus (a type of brain damage). On the other hand, although no definitive studies have been performed on humans regarding the safety of Bactroban during pregnancy or lactation period it should also be only used when clearly needed under doctor’s supervision.
How much do Silvadene and Bactroban cost?
For the brand name versions of these drugs:
- The price of 85 grams (g) of Silvadene cream (1%) averages around $70, which works out to approximately $0.82 per gram.
- The price for a tube containing 15 g of Bactroban ointment (2 %) is about $45, thus averaging at roughly $3 per gram.
Therefore, if your wound requires larger amounts of topical antibiotic treatment i.e., more than 1 g/day then Silvadene comes out as less expensive on a per-day treatment basis. However, it's important to remember that cost should not be the primary factor in determining which medication is most suitable for you.
As for generic versions - silver sulfadiazine (the active ingredient in Silvadene) and mupirocin (found in Bactroban), costs can significantly vary but are generally lower:
- Silver sulfadiazine cream costs range from around $10-$20 for an 85 g tube or roughly between $0.11 and$0.23 per gram.
- Generic Mupirocin ranges from about $13-$30 for a 22g tube coming down to an approximate cost between $0.59 –$1.36 /gram depending upon where it's purchased from.
It is always best to consult with your healthcare provider who will take into account both the nature/severity of your condition and economic considerations when prescribing medications.
Popularity of Silvadene and Bactroban
Silvadene (generic name: silver sulfadiazine) and Bactroban (generic name: mupirocin) are both topical antibiotics used in the treatment of skin infections.
In 2020, Silvadene was estimated to have been prescribed to about 1.8 million people in the US, accounting for around 25% of all prescriptions for topical antibiotics. Silvadene is particularly known for its usage in preventing and treating bacterial or yeast infections that can occur with severe burns.
Bactroban, on the other hand, was prescribed to approximately 3.7 million people in the USA during the same year. This accounts for just under 50% of prescriptions for topical antibiotics within this period. Unlike Silvadene which is primarily used on more serious wounds like burns due to its potential side effects including a sulfa allergy, Bactroban is often used more broadly on minor cuts, scrapes or surgical incisions as it has fewer associated risks.
It's important to note that while these two medications serve similar purposes - prevention and treatment of skin infections - they are typically utilized differently based on severity and type of wound.
Conclusion
Both Silvadene (silver sulfadiazine) and Bactroban (mupirocin) have a long track record of effectiveness in treating bacterial skin infections. They are backed by extensive clinical studies indicating that they are more effective than placebo treatments at preventing and treating these types of infections. However, due to their different mechanisms of action - with Silvadene acting primarily as a broad-spectrum antibacterial agent used for burn wounds and Bactroban specifically targeting gram-positive bacteria such as Staphylococcus aureus and Streptococcus pyogenes - they tend to be prescribed under different circumstances.
Silvadene is often considered the first-line treatment option for severe burns, whereas Bactroban would typically be prescribed for less serious skin conditions like impetigo or minor cuts and abrasions. Both medications come in generic form, which can offer significant cost savings especially for patients paying out-of-pocket.
Neither drug should result in immediate effects as both require some time to clear the infection; however, if symptoms persist or worsen after several days of use, medical help should be sought immediately.
The side effect profiles between these two drugs are somewhat similar: both being generally well-tolerated but may cause local irritation or allergic reactions on rare occasions. For all topical antibiotics including Silvadene and Bactroban, it's important to apply them only as directed by your healthcare provider while closely monitoring your wound's progress.